NCT04291105
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04291105
Title Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Vyriad, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | BRA

Facility Status City State Zip Country Details
Saint John's Health Center - John Wayne Cancer Institute (JWCI) Santa Monica California 90404 United States Details
Yale University New Haven Connecticut 06520-8032 United States Details
University of Miami Miami Florida 33136 United States Details
Ochsner Clinic Foundation New Orleans Louisiana 70121 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Billings Clinic Montana Cancer Consortium Billings Montana 59101 United States Details
Icahn School of Medicine at Mount Sinai New York New York 10029 United States Details
University of Cincinnati Medical Center Cincinnati Ohio 45219 United States Details
Sanford Cancer Center Sioux Falls South Dakota 57104 United States Details
Hospital Sao Rafael Salvador BR 41253-190 Brazil Details
INCA Rio de Janeiro Rio de Janeiro 20231-050 Brazil Details
Hospital Moinhos de Vento Porto Alegre Rio Grande do Sul 90035-000 Brazil Details
Hospital de Amor de Barretos Barretos São Paulo 14.784-400 Brazil Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field